Skip to content

Clinical trials

Phase 3 Dyslipidemias trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 3 Country / region: Czechia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20068
20122
20132
20141
20161
20171
20212
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda7
Amgen3
Novartis Pharmaceuticals3
NewAmsterdam Pharma2
89bio, Inc.1
Abbott1
AstraZeneca1
Boehringer Ingelheim1
Hoffmann-La Roche1
Kowa Research Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias23
Hypercholesterolemia9
Glucose Metabolism Disorders7
Diabetes Mellitus6
Diabetes Mellitus, Type 26
Hyperlipidemias5
Cardiovascular Diseases3
Hyperlipoproteinemia Type II3
Atherosclerosis2
Hypertriglyceridemia2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.